Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?

Bristol-Myers Squibb's Pravachol is gaining share in the retail market in the early days following the withdrawal of Bayer's Baycol, prescription tracking data from ArcLight indicate.

More from Archive

More from Pink Sheet